Literature DB >> 9614620

Apolipoprotein E polymorphism and renal function in German type 1 and type 2 diabetic patients.

E Werle1, W Fiehn, C Hasslacher.   

Abstract

OBJECTIVE: To examine the association of renal function in diabetic patients with apolipoprotein (apo) E polymorphism. RESEARCH DESIGN AND METHODS: Apo E genotypes, lipid and lipoprotein serum levels, creatinine clearance (CCr), and excretion of marker proteins were determined in German type 1 (IDDM; n = 162) and type 2 (NIDDM; n = 124) diabetic patients. Albumin and immunoglobulin (Ig) G are considered to reflect charge-size permselectivity of the glomerular capillary basement membrane, and increased alpha 1-microglobulin (MG) excretion indicates compromised reabsorptive capacity of the renal tubules.
RESULTS: Patients with NIDDM had higher lipid levels and lower CCrs than patients with IDDM. In patients with IDDM, age- and sex-adjusted analysis of variance showed an association between apo E genotypes and CCr, and the Jonckheere-Terpstra test demonstrated a decreasing glomerular filtration rate in the following order of genotypes: epsilon 4 epsilon 4/epsilon 4 epsilon 3 > epsilon 3 epsilon 3 > epsilon 2 epsilon 2/epsilon 2 epsilon 3. Multiple linear regression analyses revealed that in patients with IDDM, the epsilon 2 allele was a negative predictor of CCr and a positive predictor of urinary excretion of albumin, IgG and alpha 1-MG independent from HDL and LDL cholesterol, TG concentration, age, and sex.
CONCLUSIONS: Apo E polymorphism influences serum lipoprotein levels in patients with IDDM and NIDDM. Apo E polymorphism may be a renal risk factor of clinical relevance in normolipidemic patients with IDDM.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9614620     DOI: 10.2337/diacare.21.6.994

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  13 in total

Review 1.  APOE polymorphism and diabetic nephropathy.

Authors:  Shin-ichi Araki
Journal:  Clin Exp Nephrol       Date:  2013-09-13       Impact factor: 2.801

Review 2.  Lipids and diabetic nephropathy.

Authors:  Rey F Rosario; Sharma Prabhakar
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

3.  Role of apolipoprotein E in renal damage protection.

Authors:  F Bonomini; L F Rodella; M Moghadasian; C Lonati; R Coleman; R Rezzani
Journal:  Histochem Cell Biol       Date:  2011-05-15       Impact factor: 4.304

4.  A retrospective study on the influence of apolipoprotein e and serum lipids in progressive renal failure.

Authors:  L Roussos; Peter-Nilsson Ehle; Claes-Henrik Florén
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

Review 5.  [Possible genetic causes for late complications of diabetes mellitus].

Authors:  T Klemm; R Paschke
Journal:  Med Klin (Munich)       Date:  2000-01-15

6.  Apolipoprotein-defined lipoproteins and apolipoproteins: associations with abnormal albuminuria in type 1 diabetes in the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohort.

Authors:  Alicia J Jenkins; Jeremy Yu; Petar Alaupovic; Arpita Basu; Richard L Klein; Maria Lopes-Virella; Nathaniel L Baker; Kelly J Hunt; Daniel T Lackland; W Timothy Garvey; Timothy J Lyons
Journal:  J Diabetes Complications       Date:  2013-07-11       Impact factor: 2.852

7.  Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathway.

Authors:  Sanjeev Sethi; Jeffrey D Gamez; Julie A Vrana; Jason D Theis; H Robert Bergen; Peter F Zipfel; Ahmet Dogan; Richard J H Smith
Journal:  Kidney Int       Date:  2009-01-28       Impact factor: 10.612

8.  Quantitative trait loci for urinary albumin in crosses between C57BL/6J and A/J inbred mice in the presence and absence of Apoe.

Authors:  Carolien Doorenbos; Shirng-Wern Tsaih; Susan Sheehan; Naoki Ishimori; Gerjan Navis; Gary Churchill; Keith Dipetrillo; Ron Korstanje
Journal:  Genetics       Date:  2008-05       Impact factor: 4.562

9.  The relationship of the apolipoprotein E gene polymorphism Turkish Type 2 diabetic patients with and without nephropathy.

Authors:  M Erdogan; Z Eroglu; C Biray; M Karadeniz; S Cetinkalp; B Kosova; C Gunduz; N Topcuoglu; G Ozgen; C Yilmaz
Journal:  J Endocrinol Invest       Date:  2009-03       Impact factor: 4.256

10.  Association of APOE polymorphism with chronic kidney disease in a nationally representative sample: a Third National Health and Nutrition Examination Survey (NHANES III) Genetic Study.

Authors:  Audrey Y Chu; Rulan S Parekh; Brad C Astor; Josef Coresh; Yvette Berthier-Schaad; Michael W Smith; Alan R Shuldiner; Wen Hong L Kao
Journal:  BMC Med Genet       Date:  2009-10-23       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.